Longevity, Performance & Obesity Research (60 Capsules) (5-Amino-1MQ, NMN, JBSNF)
€379.50
Longevity, Performance & Obesity Research (60 Capsules) (5-Amino-1MQ, NMN, JBSNF)
Products from this Web Site are NOT intended to be used to diagnose or treat any medical condition or disease. Products on this website are sold for laboratory research purposes only and are for in-vitro lab research use only.
The products are not medicines or drugs and they have not been approved by the fda to prevent, treat, diagnose, mitigate, or cure any disease, ailment or medical condition.
Out of stock
Email me when product is available
Description
[vc_row el_class=”m-b-md”][vc_column][vc_column_text]Each Capsule contains 5-Amino-1MQ 50mg, NMN 50mg, JBSNF 5mg
5-amino-1MQ is a small molecule that blocks the activity of the enzyme called nicotinamide N-methyltransferase (NNMT). By blocking NNMT, 5-amino-1MQ stimulates an increase in NAD+, a cofactor that is central to cellular metabolism, thereby increasing metabolic rate and activating a gene called sirtuin-1 (SIRT1). SIRT1 is also known as the “longevity gene” because of its role in reducing the risk of diabetes, obesity, metabolic syndrome, atherosclerosis and other forms of cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer.
NMN (Nicotinamide mononucleotide) is an enzyme critical to the metabolism of NAD and thus a key player in metabolic regulation. Research has shown NMN to decrease age-associated body weight gain, improve energy metabolism, improved insulin sensitivity and plasma lipid profile, enhanced eye function and other pathophysiology’s.
JBSNF-000088 inhibits NNMT activity, reduces MNA levels and drives insulin sensitization, glucose modulation and body weight reduction in animal models of metabolic disease. In mice with high fat diet (HFD)-induced obesity, JBSNF-000088 caused a reduction in body weight, improved insulin sensitivity and normalized glucose tolerance to the level of lean control mice.
These three compounds affect everything from energy metabolism to cellular performance and aging. They primarily by affecting levels of NAD, the expression of GLUT-4 receptors, the activity of the NNMT enzyme and the production of molecules known as sirtuins. By increasing levels of NAD and decreasing the activity of NNMT, these molecules work together to improve cellular metabolism, enhance weight loss, and improve glucose control. Further benefits of the synergy between these peptides are seen in cellular aging, where increased levels of NAD help stem cells to survive and thrive. This provides a pool of healthy cells that can readily take the place of those that are worn or damaged, leading to improved tissue function and decreasing the effects of aging. By combining these three peptides, it might be possible to drastically alter energy metabolism for the better while simultaneously boosting anti-aging, anti-inflammatory, and anti-apoptosis activity in cells.[/vc_column_text][/vc_column][/vc_row]
